This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Diabetes Landscape: Market, Technology And Intellectual Property

NEW YORK, March 28, 2013 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Diabetes Landscape: Market, Technology and Intellectual Property .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

There are as many as 183 million people unaware that they have diabetes, including at least 78% of people with diabetes in Africa. In some of the poorest regions in the world, where infectious diseases have traditionally been the focus of healthcare systems, diabetes cases are expected to increase by 90% by 2030.

While most of the increase in diabetes prevalence is associated with the Type 2 form, the IDF also estimates there is a 3% increase annually in Type 1 diabetes in children aged under 15. Its data show there were 490,100 children in this age group globally with the condition in 2011 and the number of cases is rising by 77,800 annually.

The human costAccording to the World Health Organisation, 50% of people with diabetes die of cardiovascular disease, primarily heart disease or stroke. After 15 years of diabetes, approximately 2% of people become blind and about 10% develop severe visual impairment. In addition, 10 to 20% die of kidney failure, while diabetic neuropathy affects up to 50% of people with diabetes.

A global challengeAlthough seen as a problem mainly affecting Western countries, in fact, 80% of people with diabetes live in low and middle income countries. The IDF estimates that the Western Pacific Region had the highest number of people with diabetes aged 20 to 79 years, at 132 million, while the African Region had the smallest number, at 15 million in 2011. However, the region with the highest comparative prevalence was the Middle East and North Africa, at 11%, followed by the North America and Caribbean Region, at 10.7%. Prevalence in the Western Pacific Region was significantly lower, at 8.3%, while prevalence in the Europe region was 6.7%, representing the lowest after Africa.

Monitoring and treatment – critical components in disease managementSuccessful diabetes management is dependent on being able to accurately monitor blood glucose levels. That requires a range of both clinician and patient devices that are accurate, reliable and convenient. In addition, products that enable simple and convenient insulin delivery are needed by the quarter of diabetes patients that are insulin-dependent. The burgeoning diabetes burden represents a fast growing market place for companies who can supply those products.

"Who owns the rights to this technology? What trends are emerging? These and other questions are answered in this unmatched 2-volume report. Published by Espicom and UBM TechInsights, the report brings together their expertise to produce a study of insight and value."

1 of 4

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs